Preparation of honokiol nanoparticles by liquid antisolvent precipitation technique, characterization, pharmacokinetics, and evaluation of inhibitory effect on HepG2 cells

Weiwei Wu,1 Li Wang,2 Lingling Wang,2 Yuangang Zu,2 Siying Wang,2 Peiyan Liu,2 Xiuhua Zhao2 1Key Laboratory of Saline-Alkali Vegetation Ecology Restoration in Oil Field (SAVER), Northeast Forestry University, Harbin, China; 2Key Laboratory of Forest Plant Ecology, Northeast Forestry University, Min...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wu W, Wang L, Zu Y, Wang S, Liu P, Zhao X
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	Honokiol honokiol nanoparticles solubility bioavailability. Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/78aec8cb3baf44a195fad0a2257fe00e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:78aec8cb3baf44a195fad0a2257fe00e
record_format	dspace
spelling	oai:doaj.org-article:78aec8cb3baf44a195fad0a2257fe00e2021-12-02T00:08:34ZPreparation of honokiol nanoparticles by liquid antisolvent precipitation technique, characterization, pharmacokinetics, and evaluation of inhibitory effect on HepG2 cells1178-2013https://doaj.org/article/78aec8cb3baf44a195fad0a2257fe00e2018-09-01T00:00:00Zhttps://www.dovepress.com/preparation-of-honokiol-nanoparticles-by-liquid-antisolvent-precipitat-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Weiwei Wu,1 Li Wang,2 Lingling Wang,2 Yuangang Zu,2 Siying Wang,2 Peiyan Liu,2 Xiuhua Zhao2 1Key Laboratory of Saline-Alkali Vegetation Ecology Restoration in Oil Field (SAVER), Northeast Forestry University, Harbin, China; 2Key Laboratory of Forest Plant Ecology, Northeast Forestry University, Ministry of Education, Harbin, Heilongjiang, China Background: Honokiol is a bioactive lignanoid and has been utilized in traditional Chinese medicine for a long time. It exhibits several pharmacological properties, such as anticancer effects, anti-inflammatory effects, and antianxiety effects. However, the poor aqueous solubility of honokiol has impeded clinical applications. Materials and methods: In the present study, we adopted the liquid antisolvent precipitation (LAP) technique to prepare nanoparticles of honokiol for enhancement of solubility and bioavailability. Moreover, the honokiol nanoparticles obtained were investigated and evaluated in terms of morphology, physicochemical properties, saturation solubility, dissolution in vitro, bioavailability in vivo, toxicity, and the inhibitory effect on growth of HepG2 cells. Results: The obtained honokiol nanoparticles existed nearly in spherical shape and could be turned into amorphous structure by the LAP method. Moreover, the solubility of the honokiol nanoparticles was extremely higher than that of free honokiol, and the nanoparticle dissolution rate was also higher than that of free honokiol, which was about 20.41 times and 26.2 times than that of free honokiol in artificial gastric juice and in artificial intestinal juice. The area under the curve [AUC(0–t)] value of honokiol nanoparticles was about 6.52 times greater than that of free honokiol; therefore, the honokiol nanoparticles had a higher bioavailability than free honokiol but were innoxious to the organs of rats. Additionally, the honokiol nanoparticles exhibited a higher inhibition of HepG2 cells due to their lower IC50 compared to free honokiol. Conclusion: Honokiol nanoparticles have high solubility and bioavailability, and can become a new oral drug formulation and produce a better response for its clinical applications. Keywords: honokiol, honokiol nanoparticles, solubility, bioavailabilityWu WWang LWang LZu YWang SLiu PZhao XDove Medical PressarticleHonokiolhonokiol nanoparticlessolubilitybioavailability.Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 13, Pp 5469-5483 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Honokiol honokiol nanoparticles solubility bioavailability. Medicine (General) R5-920
spellingShingle	Honokiol honokiol nanoparticles solubility bioavailability. Medicine (General) R5-920 Wu W Wang L Wang L Zu Y Wang S Liu P Zhao X Preparation of honokiol nanoparticles by liquid antisolvent precipitation technique, characterization, pharmacokinetics, and evaluation of inhibitory effect on HepG2 cells
description	Weiwei Wu,1 Li Wang,2 Lingling Wang,2 Yuangang Zu,2 Siying Wang,2 Peiyan Liu,2 Xiuhua Zhao2 1Key Laboratory of Saline-Alkali Vegetation Ecology Restoration in Oil Field (SAVER), Northeast Forestry University, Harbin, China; 2Key Laboratory of Forest Plant Ecology, Northeast Forestry University, Ministry of Education, Harbin, Heilongjiang, China Background: Honokiol is a bioactive lignanoid and has been utilized in traditional Chinese medicine for a long time. It exhibits several pharmacological properties, such as anticancer effects, anti-inflammatory effects, and antianxiety effects. However, the poor aqueous solubility of honokiol has impeded clinical applications. Materials and methods: In the present study, we adopted the liquid antisolvent precipitation (LAP) technique to prepare nanoparticles of honokiol for enhancement of solubility and bioavailability. Moreover, the honokiol nanoparticles obtained were investigated and evaluated in terms of morphology, physicochemical properties, saturation solubility, dissolution in vitro, bioavailability in vivo, toxicity, and the inhibitory effect on growth of HepG2 cells. Results: The obtained honokiol nanoparticles existed nearly in spherical shape and could be turned into amorphous structure by the LAP method. Moreover, the solubility of the honokiol nanoparticles was extremely higher than that of free honokiol, and the nanoparticle dissolution rate was also higher than that of free honokiol, which was about 20.41 times and 26.2 times than that of free honokiol in artificial gastric juice and in artificial intestinal juice. The area under the curve [AUC(0–t)] value of honokiol nanoparticles was about 6.52 times greater than that of free honokiol; therefore, the honokiol nanoparticles had a higher bioavailability than free honokiol but were innoxious to the organs of rats. Additionally, the honokiol nanoparticles exhibited a higher inhibition of HepG2 cells due to their lower IC50 compared to free honokiol. Conclusion: Honokiol nanoparticles have high solubility and bioavailability, and can become a new oral drug formulation and produce a better response for its clinical applications. Keywords: honokiol, honokiol nanoparticles, solubility, bioavailability
format	article
author	Wu W Wang L Wang L Zu Y Wang S Liu P Zhao X
author_facet	Wu W Wang L Wang L Zu Y Wang S Liu P Zhao X
author_sort	Wu W
title	Preparation of honokiol nanoparticles by liquid antisolvent precipitation technique, characterization, pharmacokinetics, and evaluation of inhibitory effect on HepG2 cells
title_short	Preparation of honokiol nanoparticles by liquid antisolvent precipitation technique, characterization, pharmacokinetics, and evaluation of inhibitory effect on HepG2 cells
title_full	Preparation of honokiol nanoparticles by liquid antisolvent precipitation technique, characterization, pharmacokinetics, and evaluation of inhibitory effect on HepG2 cells
title_fullStr	Preparation of honokiol nanoparticles by liquid antisolvent precipitation technique, characterization, pharmacokinetics, and evaluation of inhibitory effect on HepG2 cells
title_full_unstemmed	Preparation of honokiol nanoparticles by liquid antisolvent precipitation technique, characterization, pharmacokinetics, and evaluation of inhibitory effect on HepG2 cells
title_sort	preparation of honokiol nanoparticles by liquid antisolvent precipitation technique, characterization, pharmacokinetics, and evaluation of inhibitory effect on hepg2 cells
publisher	Dove Medical Press
publishDate	2018
url	https://doaj.org/article/78aec8cb3baf44a195fad0a2257fe00e
work_keys_str_mv	AT wuw preparationofhonokiolnanoparticlesbyliquidantisolventprecipitationtechniquecharacterizationpharmacokineticsandevaluationofinhibitoryeffectonhepg2cells AT wangl preparationofhonokiolnanoparticlesbyliquidantisolventprecipitationtechniquecharacterizationpharmacokineticsandevaluationofinhibitoryeffectonhepg2cells AT wangl preparationofhonokiolnanoparticlesbyliquidantisolventprecipitationtechniquecharacterizationpharmacokineticsandevaluationofinhibitoryeffectonhepg2cells AT zuy preparationofhonokiolnanoparticlesbyliquidantisolventprecipitationtechniquecharacterizationpharmacokineticsandevaluationofinhibitoryeffectonhepg2cells AT wangs preparationofhonokiolnanoparticlesbyliquidantisolventprecipitationtechniquecharacterizationpharmacokineticsandevaluationofinhibitoryeffectonhepg2cells AT liup preparationofhonokiolnanoparticlesbyliquidantisolventprecipitationtechniquecharacterizationpharmacokineticsandevaluationofinhibitoryeffectonhepg2cells AT zhaox preparationofhonokiolnanoparticlesbyliquidantisolventprecipitationtechniquecharacterizationpharmacokineticsandevaluationofinhibitoryeffectonhepg2cells
_version_	1718403936283525120

Preparation of honokiol nanoparticles by liquid antisolvent precipitation technique, characterization, pharmacokinetics, and evaluation of inhibitory effect on HepG2 cells

Ejemplares similares